The design and deployment of the HELEX septal occluder

Jeffrey W. Delaney, Kak Chen Chan, John F. Rhodes

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The GORE HELEX Septal Occluder™ (W.L. Gore and Associates, Flagstaff, Ariz, USA) is the latest device to pursue U.S. Food and Drug Administration (FDA) approval for the closure of secundum atrial septal defects. The device is soft and compliant with comparatively little metal framework. It can be deployed and retrieved without damaging the device, and has a safety cord attached that allows retrieval even after it has been disconnected from the delivery mandrel. With FDA approval, operators will now have a choice of devices for the closure of atrial septal defects. Significant differences exist between the HELEX device and existing atrial septal occluders. This article explains the HELEX device design, provides recommendations for preprocedural screening and preparation, and discusses the deployment technique in detail. The device may be particularly advantageous for patients with small- to moderate-sized atrial septal defects.

Original languageEnglish (US)
Pages (from-to)202-209
Number of pages8
JournalCongenital Heart Disease
Volume1
Issue number5
DOIs
StatePublished - Sep 1 2006

Fingerprint

Septal Occluder Device
Equipment and Supplies
Atrial Heart Septal Defects
Drug Approval
Equipment Design
United States Food and Drug Administration
Metals
Safety
Food

Keywords

  • Catheterization
  • HELEX septal occluder
  • Secundum ASD

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Surgery
  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

The design and deployment of the HELEX septal occluder. / Delaney, Jeffrey W.; Chan, Kak Chen; Rhodes, John F.

In: Congenital Heart Disease, Vol. 1, No. 5, 01.09.2006, p. 202-209.

Research output: Contribution to journalArticle

Delaney, Jeffrey W. ; Chan, Kak Chen ; Rhodes, John F. / The design and deployment of the HELEX septal occluder. In: Congenital Heart Disease. 2006 ; Vol. 1, No. 5. pp. 202-209.
@article{9573431fe41f4319911416ce50b300cc,
title = "The design and deployment of the HELEX septal occluder",
abstract = "The GORE HELEX Septal Occluder™ (W.L. Gore and Associates, Flagstaff, Ariz, USA) is the latest device to pursue U.S. Food and Drug Administration (FDA) approval for the closure of secundum atrial septal defects. The device is soft and compliant with comparatively little metal framework. It can be deployed and retrieved without damaging the device, and has a safety cord attached that allows retrieval even after it has been disconnected from the delivery mandrel. With FDA approval, operators will now have a choice of devices for the closure of atrial septal defects. Significant differences exist between the HELEX device and existing atrial septal occluders. This article explains the HELEX device design, provides recommendations for preprocedural screening and preparation, and discusses the deployment technique in detail. The device may be particularly advantageous for patients with small- to moderate-sized atrial septal defects.",
keywords = "Catheterization, HELEX septal occluder, Secundum ASD",
author = "Delaney, {Jeffrey W.} and Chan, {Kak Chen} and Rhodes, {John F.}",
year = "2006",
month = "9",
day = "1",
doi = "10.1111/j.1747-0803.2006.00036.x",
language = "English (US)",
volume = "1",
pages = "202--209",
journal = "Congenital Heart Disease",
issn = "1747-079X",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - The design and deployment of the HELEX septal occluder

AU - Delaney, Jeffrey W.

AU - Chan, Kak Chen

AU - Rhodes, John F.

PY - 2006/9/1

Y1 - 2006/9/1

N2 - The GORE HELEX Septal Occluder™ (W.L. Gore and Associates, Flagstaff, Ariz, USA) is the latest device to pursue U.S. Food and Drug Administration (FDA) approval for the closure of secundum atrial septal defects. The device is soft and compliant with comparatively little metal framework. It can be deployed and retrieved without damaging the device, and has a safety cord attached that allows retrieval even after it has been disconnected from the delivery mandrel. With FDA approval, operators will now have a choice of devices for the closure of atrial septal defects. Significant differences exist between the HELEX device and existing atrial septal occluders. This article explains the HELEX device design, provides recommendations for preprocedural screening and preparation, and discusses the deployment technique in detail. The device may be particularly advantageous for patients with small- to moderate-sized atrial septal defects.

AB - The GORE HELEX Septal Occluder™ (W.L. Gore and Associates, Flagstaff, Ariz, USA) is the latest device to pursue U.S. Food and Drug Administration (FDA) approval for the closure of secundum atrial septal defects. The device is soft and compliant with comparatively little metal framework. It can be deployed and retrieved without damaging the device, and has a safety cord attached that allows retrieval even after it has been disconnected from the delivery mandrel. With FDA approval, operators will now have a choice of devices for the closure of atrial septal defects. Significant differences exist between the HELEX device and existing atrial septal occluders. This article explains the HELEX device design, provides recommendations for preprocedural screening and preparation, and discusses the deployment technique in detail. The device may be particularly advantageous for patients with small- to moderate-sized atrial septal defects.

KW - Catheterization

KW - HELEX septal occluder

KW - Secundum ASD

UR - http://www.scopus.com/inward/record.url?scp=33748570728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748570728&partnerID=8YFLogxK

U2 - 10.1111/j.1747-0803.2006.00036.x

DO - 10.1111/j.1747-0803.2006.00036.x

M3 - Article

C2 - 18377527

AN - SCOPUS:33748570728

VL - 1

SP - 202

EP - 209

JO - Congenital Heart Disease

JF - Congenital Heart Disease

SN - 1747-079X

IS - 5

ER -